GeoVax Labs GOVX
NASDAQ GOVX
$0.23 +0.01 (+3.32%)
As of: Oct 21, 2026 · 12:42 PM EDT

GeoVax Labs (GOVX) Other financing activities (2010 - 2011)

Updated

GeoVax Labs' Other financing activities came in at -$1.2 million for Q3 2022.

Analysis

GeoVax Labs (GOVX) Other financing activities (2010 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.52 Bn 1,100.11 Bn 19.71 Bn
2 Johnson & Johnson 616.33 Bn 534.86 Bn 17.26 Bn
3 AbbVie 500.08 Bn 473.19 Bn 12.70 Bn
4 Merck 366.80 Bn 321.17 Bn 12.21 Bn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn
6 Astrazeneca 261.59 Bn 235.28 Bn 12.86 Bn
7 Amgen 234.86 Bn 190.26 Bn 7.24 Bn
8 Gilead Sciences 189.95 Bn 164.15 Bn 6.22 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn
10 GeoVax Labs 1.04 Mn -13.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 -49,011.00
Dec 31, 2010 -173,229.00
Sep 30, 2010 83,503.00
API Access

GeoVax Labs Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=GOVX&period=max&api_key=YOUR_API_KEY